Livery
Livery, licence 80069341: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Milk Thistle 150 mg Softgel Capsule
- Licence holder
- MIHB Inc.
- NPN or DIN-HM
- 80069341
- Status
- Active licence
- Licence date
- 11 May 2016
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Silybum marianum Source : Fruit Potency : 80.0 % Silymarin | 150.0 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Huile de fève de soja, Lécithine, Cire d'abeille jaune, Glycérine, Dioxyde de titane, Caramel, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
(Traditionally used in Herbal Medicine as a) hepatoprotectant/ liver protectant. (Used in Herbal Medicine to) help(s) to support liver function. Used in Herbal Medicine to help relieve digestive disturbances/dyspepsia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant.
- Effets indésirables connus
Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80069341
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.